EA201070790A1 - Реанимационная жидкость - Google Patents

Реанимационная жидкость

Info

Publication number
EA201070790A1
EA201070790A1 EA201070790A EA201070790A EA201070790A1 EA 201070790 A1 EA201070790 A1 EA 201070790A1 EA 201070790 A EA201070790 A EA 201070790A EA 201070790 A EA201070790 A EA 201070790A EA 201070790 A1 EA201070790 A1 EA 201070790A1
Authority
EA
Eurasian Patent Office
Prior art keywords
resuscitation fluid
reanimation
liquid
aqueous carrier
lipid
Prior art date
Application number
EA201070790A
Other languages
English (en)
Other versions
EA022379B1 (ru
Inventor
Катберт О. Симпкинс
Original Assignee
Катберт О. Симпкинс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Катберт О. Симпкинс filed Critical Катберт О. Симпкинс
Publication of EA201070790A1 publication Critical patent/EA201070790A1/ru
Publication of EA022379B1 publication Critical patent/EA022379B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описан способ лечения состояний, связанных в недостаточностью кровоснабжения, реанимационной жидкостью на основе липида. Эта реанимационная жидкость содержит липидный компонент и водный носитель. Этот липидный компонент образует эмульсию с водным носителем. Эта реанимационная жидкость может быть использована для увеличения кровяного давления и несения кислорода к тканям. Эта реанимационная жидкость может быть также использована для сохранения биологической целостности донорских органов для трансплантации.
EA201070790A 2007-12-22 2008-12-17 Способ лечения гиповолемии, ишемии и геморрагического шока у млекопитающих EA022379B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1644307P 2007-12-22 2007-12-22
US6463908P 2008-03-18 2008-03-18
PCT/US2008/013781 WO2009082449A2 (en) 2007-12-22 2008-12-17 Resuscitation fluid

Publications (2)

Publication Number Publication Date
EA201070790A1 true EA201070790A1 (ru) 2011-02-28
EA022379B1 EA022379B1 (ru) 2015-12-30

Family

ID=40789354

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070790A EA022379B1 (ru) 2007-12-22 2008-12-17 Способ лечения гиповолемии, ишемии и геморрагического шока у млекопитающих

Country Status (15)

Country Link
US (4) US8063020B2 (ru)
EP (2) EP2227222B1 (ru)
JP (1) JP5690142B2 (ru)
KR (1) KR101623993B1 (ru)
CN (1) CN101917970B (ru)
AP (1) AP3197A (ru)
AU (1) AU2008341109B2 (ru)
CA (1) CA2710338C (ru)
EA (1) EA022379B1 (ru)
ES (1) ES2476258T3 (ru)
HK (1) HK1151972A1 (ru)
IL (1) IL206116A (ru)
NZ (1) NZ586233A (ru)
WO (1) WO2009082449A2 (ru)
ZA (1) ZA201005150B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2010087986A2 (en) * 2009-01-30 2010-08-05 Simpkins Cuthbert O Resuscitation fluid
WO2012096697A1 (en) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US10357450B2 (en) 2012-04-06 2019-07-23 Children's Medical Center Corporation Process for forming microbubbles with high oxygen content and uses thereof
BR112015002807A2 (pt) * 2012-08-10 2018-03-20 Vivacelle Bio, Inc. expansor de volume sanguíneo, métodos para tratar condições relacionadas com a falta de suprimento de sangue e para aumentar a pressão sanguínea em paciente com hipovolemia e respectivos usos
US10577554B2 (en) 2013-03-15 2020-03-03 Children's Medical Center Corporation Gas-filled stabilized particles and methods of use
EP3307283B1 (en) * 2015-06-10 2020-09-02 Cellphire Inc. Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
RU2618200C1 (ru) * 2016-01-11 2017-05-02 государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ОмГМУ Минздрава России) Способ патогенетически обоснованной оценки гиповолемии у больных с травматическим шоком II и III степени тяжести
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
US9801906B2 (en) * 2016-03-30 2017-10-31 Baylor University Oxygen-enabled fluid
WO2017222912A1 (en) * 2016-06-20 2017-12-28 Vivacelle Bio, Inc. Compositions and methods for reducing reperfusion injury
CN106237314A (zh) * 2016-08-30 2016-12-21 中国科学院长春应用化学研究所 一种应用于宠物失血休克急救的复苏液及其制备方法
WO2018039754A1 (pt) * 2016-09-01 2018-03-08 Bebeachibuli Romeo Formulação à base de fatores alimentares, produtos obtidos com o uso da formulação e processos de obtenção
US11147890B2 (en) 2017-02-28 2021-10-19 Children's Medical Center Corporation Stimuli-responsive particles encapsulating a gas and methods of use
US12005130B2 (en) 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
CN116076484A (zh) * 2022-11-30 2023-05-09 武汉大学 一种修复肾脏损伤的低温携氧机械灌注液及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835485B2 (ja) * 1976-02-03 1983-08-03 株式会社ミドリ十字 酸素運搬輸液
US4182750A (en) 1977-04-21 1980-01-08 Sullivan Thomas E Bloodcompatible functional polymers
JPS5727624A (en) * 1980-07-28 1982-02-15 Japax Inc Automatic wire setting device of wire type electric discharge processing machine
US4425334A (en) 1982-04-02 1984-01-10 The Regents Of The University Of California Functional oxygen transport system
US4911929A (en) 1986-08-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Navy Blood substitute comprising liposome-encapsulated hemoglobin
US5061688A (en) * 1988-08-19 1991-10-29 Illinois Institute Of Technology Hemoglobin multiple emulsion
WO1992022202A1 (en) * 1991-06-03 1992-12-23 Alpha Therapeutics Corporation Thrombolytic and perfluorochemical treatment for myocardial infraction
US5284663A (en) 1991-07-23 1994-02-08 Temple University Salt film encapsulated perfluorocarbons
JPH05320043A (ja) * 1992-05-20 1993-12-03 Terumo Corp リポポリサッカライド捕捉剤
EP0693924B2 (en) * 1993-02-22 2008-04-09 Abraxis BioScience, Inc. Methods for (in vivo) delivery of biologics and compositions useful therefor
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5834519A (en) 1996-10-11 1998-11-10 Wayne State University Stabilized gas-supersaturated emulsions and suspensions
US6261537B1 (en) 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
SE0000730D0 (sv) 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DK1349545T3 (da) * 2000-12-05 2009-02-16 Los Angeles Childrens Hospital Farmaceutiske præparater af fenretinid med öget biotilgængelighed samt fremgangsmåder til anvendelse deraf
US20020172710A1 (en) 2001-05-16 2002-11-21 Twine Rebecca Wright Clinical use of liposome technology for the delivery of nutrients to patients with the short bowel syndrome
EP1279400A1 (en) 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US20050260189A1 (en) 2002-07-11 2005-11-24 Klibanov Alexander L Microbubble compositions, and methods for preparing and using same
US20060166182A1 (en) 2002-12-31 2006-07-27 The Board Of Trustees Of The University Of Ilinois A Body Corporate And Politic Of The State Of Il. Tissue and organ preservation, protection and resuscitation
JP2004307404A (ja) * 2003-04-08 2004-11-04 Nipro Corp 人工酸素運搬体を含む医薬組成物
RU2259819C1 (ru) * 2004-03-01 2005-09-10 Кузнецова Ирина Николаевна Эмульсия перфторорганических соединений медицинского назначения и способ её получения
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
CN1669578A (zh) * 2004-10-15 2005-09-21 梁玉英 一种治疗心脑血管疾病的针剂及其制备方法
US20060088583A1 (en) 2004-10-25 2006-04-27 Oxygenix Co., Ltd. Artificial oxygen carrier containing preventive agents of metHb formation
WO2009043031A2 (en) 2007-09-27 2009-04-02 Children's Medical Center Corporation Microbubbles and methods for oxygen delivery
US8063020B2 (en) 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
WO2010087986A2 (en) 2009-01-30 2010-08-05 Simpkins Cuthbert O Resuscitation fluid

Also Published As

Publication number Publication date
CN101917970A (zh) 2010-12-15
ZA201005150B (en) 2011-04-28
US20120028235A1 (en) 2012-02-02
CN101917970B (zh) 2012-10-17
AU2008341109B2 (en) 2014-04-24
JP2011507844A (ja) 2011-03-10
ES2476258T3 (es) 2014-07-14
EP2227222B1 (en) 2014-06-18
CA2710338A1 (en) 2009-07-02
US8063020B2 (en) 2011-11-22
AP3197A (en) 2015-03-31
IL206116A0 (en) 2010-11-30
AU2008341109A1 (en) 2009-07-02
EA022379B1 (ru) 2015-12-30
IL206116A (en) 2015-06-30
NZ586233A (en) 2012-07-27
EP2749268B1 (en) 2019-02-20
JP5690142B2 (ja) 2015-03-25
EP2227222A2 (en) 2010-09-15
WO2009082449A2 (en) 2009-07-02
US8569236B2 (en) 2013-10-29
US20130095192A1 (en) 2013-04-18
EP2749268A1 (en) 2014-07-02
US8198243B2 (en) 2012-06-12
KR101623993B1 (ko) 2016-05-24
AP2010005297A0 (en) 2010-06-30
US8367613B2 (en) 2013-02-05
KR20100118104A (ko) 2010-11-04
CA2710338C (en) 2016-02-16
EP2227222A4 (en) 2011-03-09
US20090163418A1 (en) 2009-06-25
HK1151972A1 (en) 2012-02-17
WO2009082449A3 (en) 2009-10-01
US20120034277A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
EA201070790A1 (ru) Реанимационная жидкость
WO2010087986A3 (en) Resuscitation fluid
NZ612801A (en) Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
BRPI0711599B8 (pt) métodos para coleta e de uso de células-tronco de sangue de cordão umbilical de placenta
BR112015010078A2 (pt) vedações de stent e métodos para vedar um stent expansível
AR109529A1 (es) Dispositivo de muestreo de fluido
BR112014006216A2 (pt) instrumento cirúrgico com apoio preenchível por fluido
SG10201805199RA (en) Methods and Uses for Ex Vivo Tissue Culture Systems
BR112012029376A8 (pt) Transplantação a partir de uma gordura lobular extraida por liposucção
EA200802333A1 (ru) Соль органической кислоты, способ получения соли органической кислоты, способы и средства для лечения новообразований и лечения злокачественных новообразований крови, набор, стерильный водный раствор и композиции в упакованном и неупакованном видах
AR083552A1 (es) Una capsula para la preparacion de una bebida
EA201691297A1 (ru) Среда для культивирования клеток
AR067211A1 (es) Punta de lumen inyectora de lentes para insercion asistida en una herida
BR112012025860A2 (pt) reservatório de sangue com sensor de volume ultrassônico
BR112012000647B8 (pt) dispositivo de lubrificação implantável
CL2015002747A1 (es) Metodo para la oxigenacion extracorporea de un sujeto; y aparato de incubacion.
BR112012017994A2 (pt) composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
GB2514506A (en) Critical point drying systems and methods for in situ tissue preservation
BR112014026152A2 (pt) injetor pré-carregado para uso com lente intraocular
AR061267A1 (es) Fluidos acidos de tratamiento mejorados y metodos asociados
BR112015019197A2 (pt) tratamento de doença de enxerto versus hospedeiro em pacientes transplantados
RS53408B (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION
BR112012015505A2 (pt) método de tratamento para tratamento de superfície de um dispositivo dispensador de fluido
DE502006003267D1 (de) Tragbare Messeinrichtung zur Bestimmung einer medizinisch bedeutsamen Analytkonzentration
DE602007010938D1 (de) Lösung enthaltend n-acetylcystein und gluconsäure, und verfahren zur verringerung, behandlung und/odvierung

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM